GlassScriptPhysician profile
Jorge A Wong
NPI 1083678494
$556.09
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $542 · 2021: $13.93.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $55.11 | 2019 | |
| Tersera Therapeutics LLC | $50.44 | 2019 | |
| Lilly USA, LLC | $41.70 | 2019 | |
| Seagen INC. | $37.95 | 2019 | |
| Amgen INC. | $30.13 | 2019 | |
| Incyte Corporation | $28.37 | 2019 | |
| Novartis Pharmaceuticals Corporation | $26.48 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $25.36 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $25.21 | 2019 | |
| Tesaro, INC. | $24.51 | 2019 | |
| Celgene Corporation | $24.51 | 2019 | |
| Jazz Pharmaceuticals INC. | $23.02 | 2019 | |
| Janssen Biotech, INC. | $22.60 | 2019 | |
| Genzyme Corporation | $22.39 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.72 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $14.62 | 2019 | |
| Acrotech Biopharma INC. | $13.93 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $13.15 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.94 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $12.34 | 2019 | |
| Pfizer INC. | $12.10 | 2019 | |
| Exelixis INC. | $12.05 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $11.46 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorge Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.